-
-
-
-
-
-
-
Citi Upgrades Dimension Therapeutics (DMTX) to Neutral (Yesterday)
-
-
-
-
-
-
-
Dimension Board of Directors Determines Proposal from Ultragenyx Pharmaceutical Inc. Could Reasonably Be Expected to Lead to a “Superior Proposal”
-
-
-
-
-
-
-
Regenxbio (RGNX) to Acquire Dimension Therapeutics (DMTX) in All-Stock Transaction
-
-
-
1,158,058 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

